OREANDA-NEWS. Manulife Investments, a division of Manulife Asset Management Limited, is pleased to announce that a preliminary prospectus (the "Preliminary Prospectus") for Manulife Global Healthcare Trust (the "Fund"), a closed-end investment fund, has been filed and receipted by the securities regulatory authorities of all the Canadian provinces and territories for an initial public offering (the "Offering") of Class A Units and Class U Units of the Fund (collectively, the "Units") at a price of $10.00 per Class A Unit and US$10.00 per Class U Unit.

The Fund has been created to invest in an actively managed portfolio comprised of equity securities of global healthcare companies that are developing and commercializing drugs, therapeutic solutions and/or medical devices. Manulife Asset Management Limited (the "Manager") will act as trustee, manager and investment manager of the Fund. The Fund’s portfolio will be managed by Sectoral Asset Management Inc. (the "Advisor").

The Fund’s investment objectives are to provide Unitholders with:

   i. the opportunity for capital appreciation, and 
   ii. monthly cash distributions.

To supplement the dividend income generated by the Portfolio, the Manager has retained Sherpa Asset Management Inc. to strategically and selectively write covered call options from time to time, on securities comprising up to 25% of the value of the Fund’s portfolio.

The Fund’s initial Target Distribution Amount is expected to be $0.0416 per Class A Unit per month (or $0.50 per annum), and US$0.0416 per Class U Unit per month (or US$0.50 per annum), representing an initial yield on the original Unit issue price of 5.00% per annum.

Prospective purchasers who elect to pay for Units by using the Exchange Option must do so by depositing (in the form of a book-entry deposit) Exchange Eligible Securities (as outlined in the prospectus) with CST Trust Company, the Fund’s agent for the Exchange Option, through CDS Clearing and Depository Services Inc. ("CDS") prior to 5:00 p.m. EST on November 24, 2015 (the "Deposit Date"). Such book-entry deposits must be made by a participant in CDS, which may have an earlier deadline for receiving instructions from their clients to deposit Exchange Eligible Securities under the Exchange Option.

The number of Units issuable for each security of an Exchange Eligible Issuer (the "Exchange Ratio") will be determined by dividing the weighted average trading price of such security on the primary exchange or market on which such security is then listed during the period of five consecutive trading days ending on December 4, 2015 (the "Pricing Period"), as adjusted to reflect distributions declared by any Exchange Eligible Issuer that will not be received by the Fund, by $10.00 in respect of the Class A Units, or US$10.00 in respect of the Class U Units, as applicable. Pursuant to this press release, the Deposit Date and Pricing Period disclosed in the Preliminary Prospectus have been extended as set forth above. The Fund will issue a press release as soon as practicable following completion of the amended Pricing Period announcing for each of the Exchange Eligible Securities, among other things, the Exchange Ratio.

The offering is being conducted by a syndicate of Agents co-led by RBC Capital Markets and CIBC, and that includes BMO Capital Markets, National Bank Financial Inc., Scotiabank, TD Securities Inc., GMP Securities L.P., Manulife Securities Incorporated, Raymond James Ltd., Canaccord Genuity Corp. and Desjardins Securities Inc.

A Preliminary Prospectus containing important information relating to these securities has been filed with securities commissions or similar authorities in each of the provinces and territories of Canada. The Preliminary Prospectus is still subject to completion or amendment. Copies of the Preliminary Prospectus may be obtained from one of the dealers noted above. There will not be any sale or any acceptance of an offer to buy the securities until a receipt for the final prospectus has been issued.